R&D for Neglected Diseases
Click here for information on the debate on research and development
for neglected diseases at the 59th World Health Assembly, May 22-27, 2006.
Drugs for Neglected Disease Initiative (DNDi) Documents
Meetings on Neglected Diseases, Developing Treatments and Ensuring Access.
- Announcement for MSF-Sponsored Meeting, June 8, 2005, London.
Ensuring Innovation for Neglected Diseases.
- April 29, 2003.
International Meeting on a global framework for supporting health
research and development (R&D) in areas of market and public policy failure.
Hosted by Medicins Sans Frontieres, Consumer Project on Technology, OxFam,
Health Action International and the Third World Network.
- March 14, 2002. Crisis of Neglected Diseases: Developing Treatments and Ensuring Access.
Conference hosted by Medicins Sans Frontieres, Consumer Project on Technology, OxFam and Health Action International.
Medecins Sans Frontieres Documents
- May, 2004. Fact sheet prepared for the 57th World Health Assembly.
SLEEPING SICKNESS - or Human African Trypanosomiasis.
- September 22, 2003. Joint publication with the World Health Organization.
Surmounting challenges: procurement of antiretroviral medicines in low- and middle-income countries.
- Doctors Without Borders Delivers Petition Calling for
More Research & Development for Neglected Diseases That Kill 14 Million Every Year.
- Petitions to both President Bush
and PhRMA. Please sign before May 14, 2003.
- September 19, 2002. Press release.
Lack of appropriate vaccine catches world community unprepared as
unusual strain of meningitis threatens African countries.
- June 22, 2002. Patrice Trouiller, Piero Olliaro, Els Torreele, James Orbinski,
Richard Laing, and Nathan Ford for the Lancet.
Drug Development For Neglected Diseases: A Deficient Market And A
Public-Health Policy Failure.
- February 14, 2002. Press release.
Urgent need to kick-start R&D for killer diseases in poor countries.
- February 13, 2002. Jean-Marie Kindermans, Co-authors: Bernard Pécoul,
Carmen Perez-Casas, Margriet Den Boer, Daniel Berman, and Ingrid Cox.
Changing national malaria treatment protocols
in Africa: What is the cost and who will pay?
- December 19, 2001. Nathan Ford and Els Toreelle for the MSF Working Group on
Neglected Diseases. Letter to the Editor of the Journal of the American Medical
Neglected Diseases of Global Importance. Link also includes a response
to their letter from Gregory Folkers and Anothony Fauci of the NIH's
National Institute of Allergy and Infectious Diseases.
- October 10, 2001. MSF Cananda press release.
MSF calls on public investment to support neglected disease research: 1999
Nobel Peace prize money goes to research for treating diseases of the poor.
- October 9, 2001. MSF Report and press release.
Fatal Imbalance: The Crisis in Research and Development for Drugs for Neglected Diseases.
Also, see Ed Silverman's
story in the Star-Ledger about this report.
- January 27, 1999. Bernard Pécoul, Pierre Chirac, Patrice Trouiller,
and Jacques Pinel in the Journal of the American Medical Association.
Access to Essential Drugs in Poor Countries- A Lost Battle?
- James Love,
The Benifits of a Treaty on R&D. PPT presentation given at
The Drugs for Neglected Diseases (DND) Working Group, in Rio de
Janerio, Brazil, on December 3, 2002.
Institutions Researching Tropical Diseases
Pharmaceutical Industry Documents
- December 2003. International Federation of Pharmaceutical Manufacturers Associations.
Neglected Diseases and the Pharmaceutical Industry
- June 22, 2005. European Parliament Committee on Development.
Reporton Major and Neglected Diseases in Developing Countries.
- December 4, 2004. Andrew Farlow for the Lancet. Book Review of
Over the rainbow: the pot of gold for neglected diseases, by
Michael Kremer and Rachel Glennerster.
Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases.
- February 5, 2003. European Federation of Pharmaceutical Industries and
Associations press release.
EFPIA welcomes increased public funding for diseases of poverty,
but warns against undermining future research.
- April 1, 2003. Luis Jódar, F Marc LaForce, Costante Ceccarini, Teresa
Aguado, Dan M Granoff in the Lancet.
Meningococcal conjugate vaccine for Africa: a model for
development of new vaccines for the poorest countries.
- Onchocerciasis (River Blindness)
- NIH's National Institute of Allergy and Infectious Diseases.
NIAID Expands Malaria Research Efforts.
- London School of Hygene and Tropical Medicine
Gates Malaria Programme
- September 30, 2003. John G. Bartlett, MD. Document presented at the
43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy.
Why Is Big Pharmacy Getting Out of Anti-infective Drug Discovery?
- June 2001. Volker Lehman. Biotechnology and Development Monitor,
No. 46, p. 2-7.
New models for public-private partnerships in drug development. Includes
table of public-private partnerships formed to research neglected
- September 21, 1999.
President Clinton's Remarks to the UN on the Global Health Care Gap.
- March 29, 2007. Washington Post editorial.
A Dose of Innovation.
- June 19, 2005. Banasree Purkayastha for the Financial Express.
Glamourless diseases - With commercial interests driving drug research,
diseases like kala-azar fail to attract funds.
- February 19, 2005. Op-ed by Michael Rawlins in the British Medical Journal.
"Priority medicines for Europe and the world" is a wake up call from WHO.
- December 6, 2004. Victoria Hale for Newsweek.
Creating More Paths to Hope.
- November 29, 2004. Stephen Foley for the London Independent.
GSK Asks Blair for Tax and Patent Incentives for Research Into Neglected Diseases.
- April 29, 2004. Judith Mandelbaum-Schmid for In Focus.
New generation of non-profit initiatives tackles world's "neglected" diseases.
- February 8, 2004. Associated Press.
Prescription for the developing world:
Nonprofit buys rights to drugs long ignored by Western firms.
- September 12, 2003. Zina Moukheiber for Forbes.
Protecting The Orphan Drugs.
- June 12, 2003. Op-ed by Richard Rockefeller for the Boston Globe.
A Fatal Imbalance.
- May 15, 2003. Joe De Capua for Voice of America News.
Neglected Diseases Kill 14 Million People A Year.
- May 4, 2003. Kitta MacPherson for the new Jersey Star-Ledger.
Spotlight skips over many other outbreaks.
- March 29, 2003. Jocalyn Clark for the British Medical Journal.
Euro MPs vote on research fund for neglected diseases.
- September 26, 2002. DCMilitary.com.
Navy Medicine awarded patent.
- September 20, 2002. Naomi Koppel for the Associated Press.
Aid groups: tens of thousands could die from new meningitis strain.
- August 19, 2002. David Perlman for the San Francisco Chronicle.
Drug firm seeks cures over cash S.F. nonprofit wants to help poor
- May 28, 2002. Donald McNeil for the New York Times.
New Malaria Drug Pits US Against Africa.
- May 13, 2002. Ricki Lewis for the Scientist.
Fighting the 10/90 Gap.
- May 13, 2002. Ricki Lewis for the Scientist.
African Sleeping Sickness: A Recurring Epidemic.
- March 14. Alan Mozes for Reuters.
Research on Drugs for 'Neglected Diseases' Urged.
- March 12, 2002. Penny Fannin for The Age.
Drug firms ignoring killer diseases: report.
- February 14, 2002. Theresa Agovino for the Associated Press.
Nonprofits Seek to Develop Drugs.
- February 14, 2002. Lisa Richwine for Reuters.
U.S. Nonprofit Gets Rights to Chagas Drug from Celera.